Phibro Animal Health Corporation (PAHC) vs Rapport Therapeutics, Inc. Common Stock (RAPP)
A side-by-side comparison of Phibro Animal Health Corporation and Rapport Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PAHC
Phibro Animal Health Corporation
$37.01HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
RAPP
Rapport Therapeutics, Inc. Common Stock
$31.07HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — PAHC vs RAPP
growth of $100 · dividends reinvested · last 2yPAHC +124.7% (+49.9%/yr)RAPP +54.8% (+24.4%/yr)PAHC compounded faster over this window
PAHC RAPP
PAHC vs RAPP: by the numbers
- •PAHC is the larger company ($1.50B vs $1.49B market cap).
- •PAHC is profitable (6.57% net margin) while RAPP runs a net loss (-685.80%).
- •PAHC pays a dividend (1.29% yield), while RAPP has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | PAHC | RAPP |
|---|---|---|
| P/E ratio | 15.17 | N/A |
| Forward P/E | 10.57 | N/A |
| PEG ratio | 1.19 | N/A |
| P/S ratio | 0.99 | 74.29 |
| P/B ratio | 3.89 | 3.51 |
| EV / EBITDA | 8.91 | N/A |
| FCF yield | 0.66% | N/A |
Profitability
| Metric | PAHC | RAPP |
|---|---|---|
| Gross margin | 33.71% | 0.00% |
| Operating margin | 13.07% | 0.00% |
| Net margin | 6.57% | -685.80% |
| ROE | 25.87% | -32.43% |
| ROIC | 11.91% | -35.66% |
Dividends
| Metric | PAHC | RAPP |
|---|---|---|
| Dividend yield | 1.29% | N/A |
| Payout ratio | 19.67% | N/A |
Growth (annualized)
| Metric | PAHC | RAPP |
|---|---|---|
| Revenue CAGR (5Y) | 12.75% | N/A |
| EPS CAGR (5Y) | 12.92% | N/A |
| FCF CAGR (5Y) | -12.27% | N/A |
| Total return CAGR (5Y) | 14.40% | N/A |
Frequently asked
- Does PAHC or RAPP pay a bigger dividend?
- PAHC pays a dividend (1.29% yield), while RAPP has no payments in the available dividend history.
- Is PAHC or RAPP more profitable?
- PAHC runs the higher net margin — PAHC at 6.57% versus RAPP at -685.80%.
Go deeper
Dig into the metrics
Phibro Animal Health P/E ratioPhibro Animal Health dividend yieldPhibro Animal Health ROERapport Therapeutics, Inc. Common Stock ROEPhibro Animal Health operating marginRapport Therapeutics, Inc. Common Stock operating marginPhibro Animal Health revenue growthRapport Therapeutics, Inc. Common Stock revenue growthPhibro Animal Health free cash flowRapport Therapeutics, Inc. Common Stock free cash flow
Phibro Animal Health & Rapport Therapeutics, Inc. Common Stock appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.